Akari Therapeutics Plc Quarterly Interest Expense in USD from Q3 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Akari Therapeutics Plc quarterly/annual Interest Expense history and growth rate from Q3 2014 to Q2 2024.
  • Akari Therapeutics Plc Interest Expense for the quarter ending June 30, 2024 was $51K.
  • Akari Therapeutics Plc annual Interest Expense for 2017 was $0.000.
  • Akari Therapeutics Plc annual Interest Expense for 2016 was $0.000, a 100% decline from 2015.
  • Akari Therapeutics Plc annual Interest Expense for 2015 was $3.05K, a 43.8% decline from 2014.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $51K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q2 2016 -$4.12K $0 -$2.61K -100% Apr 1, 2016 Jun 30, 2016 6-K/A 2017-04-14
Q1 2016 -$1.5K $0 -$4.56K -100% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $3.05K -$7.17K Oct 1, 2015 Dec 31, 2015 20-F 2018-07-18
Q3 2015 $3.05K +$172 +5.98% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-23
Q2 2015 $2.61K Apr 1, 2015 Jun 30, 2015 6-K/A 2017-04-14
Q1 2015 $4.56K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 $2.88K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.